NDC 51655-727
levothyroxine sodium 150 ug tablet
On the label: Northwind Pharmaceuticals. It's repackaged: Northwind Pharmaceuticals rebottles it from Alvogen Inc.'s NDC 47781-662.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Alvogen Inc. names for other drugs.
Repackaging site
- Northwind Health Company, LLC, Indianapolis, IN, United States · repackages it
Recalls
- Dec 31, 2025 · Class II · Alvogen, Inc
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Lots: Lot # MHA21825, Exp Date: December 31, 2027
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Levothyroxine: every company that makes it
- Form
- tablet, oral
- Strength
- 150 ug
- Approval
- NDA NDA021116
- On the market since
- Jun 11, 2021
- Package NDCs
51655-727-52- Official label
- DailyMed (National Library of Medicine), updated Jan 1, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?